FLXN
COM:FLEXIONTHERAPEUTICS
Flexion Therapeutics
- Stock
Last Close
9.12
01/01 00:00
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
|---|---|---|---|---|---|---|---|---|
net income | -27.31M - | -46.32M 69.57% | -71.89M 55.23% | -137.48M 91.23% | -169.66M 23.41% | -149.77M 11.72% | -113.71M 24.08% | |
depreciation and amortization | 120.34K - | 238.15K 97.90% | 1.15M 383.29% | 2.01M 74.46% | 1.71M 14.64% | 2.40M 39.79% | 3.34M 39.48% | |
deferred income tax | ||||||||
stock based compensation | 2.45M - | 4.58M 87.00% | 6.77M 47.73% | 11.54M 70.49% | 15.46M 33.94% | 15.90M 2.86% | 18.58M 16.83% | |
change in working capital | 1.22M - | 1.48M 22.10% | -1.00M 167.70% | 11.80M 1,274.50% | -14.20M 220.39% | -25.54M 79.82% | 8.83M 134.57% | |
accounts receivables | 95.28K - | -410K 530.29% | -12.71M 3,000.24% | -23.99M 88.77% | 7.09M 129.55% | |||
inventory | 2.77M - | -1.80M 165.04% | -5.24M 191.50% | -7.67M 46.34% | -922K 87.99% | |||
accounts payables | 518.03K - | 1.58M 205.23% | -992.74K 162.79% | 4.19M 521.86% | 5.14M 22.76% | 1.70M 66.89% | -6.56M 485.43% | |
other working capital | 697.06K - | -97.48K 113.98% | -2.87M 2,847.29% | 9.82M 441.77% | -1.39M 114.16% | 4.42M 418.35% | 9.22M 108.41% | |
other non cash items | 382.73K - | 1.06M 177.56% | 2.51M 135.90% | 4.30M 71.67% | 6.27M 45.77% | 8.26M 31.70% | 12.40M 50.09% | |
net cash provided by operating activities | -23.14M - | -38.95M 68.28% | -62.47M 60.40% | -107.83M 72.61% | -160.42M 48.77% | -148.76M 7.27% | -70.56M 52.57% | |
investments in property plant and equipment | -802.48K - | -5.20M 547.66% | -8.44M 62.38% | -2.15M 74.57% | -852K 60.30% | -3.89M 357.04% | -10.07M 158.58% | |
acquisitions net | ||||||||
purchases of investments | -79.38M - | -145.80M 83.66% | -196.06M 34.47% | -356.75M 81.96% | -222.48M 37.64% | -115.47M 48.10% | -79.62M 31.05% | |
sales maturities of investments | 30.73M - | 137.70M 348.03% | 72.15M 47.61% | 240.23M 232.97% | 348.92M 45.24% | 234.12M 32.90% | 66.90M 71.43% | |
other investing activites | 48K - | -400K 933.33% | -120K 70% | 25K - | ||||
net cash used for investing activites | -49.45M - | -13.24M 73.22% | -132.75M 902.31% | -118.79M 10.52% | 125.58M 205.72% | 114.76M 8.62% | -22.76M 119.83% | |
debt repayment | -1.50M - | -3.50M 133.33% | -8.33M - | -10M 20.00% | -14.37M 43.67% | -15M 4.41% | ||
common stock issued | 162.14M - | 147.89M - | 132.67M 10.29% | 97.29M - | ||||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | -1.13M - | 15.54M 1,472.35% | 15.31M 1.50% | 199.16M 1,201.12% | 3.67M 98.15% | 43.38M 1,080.54% | 36.49M 15.90% | |
net cash used provided by financing activities | 159.51M - | 12.04M 92.45% | 163.20M 1,255.46% | 323.50M 98.23% | -6.33M 101.96% | 29.02M 558.78% | 118.78M 309.31% | |
effect of forex changes on cash | ||||||||
net change in cash | 86.91M - | -40.15M 146.20% | -32.03M 20.23% | 96.87M 402.46% | -41.16M 142.49% | -4.98M 87.91% | 25.45M 611.48% | |
cash at beginning of period | 16.19M - | 103.10M 536.87% | 62.94M 38.95% | 30.91M 50.88% | 128.39M 315.30% | 87.23M 32.06% | 82.25M 5.70% | |
cash at end of period | 103.10M - | 62.94M 38.95% | 30.92M 50.88% | 127.79M 313.35% | 87.23M 31.74% | 82.25M 5.70% | 107.70M 30.94% | |
operating cash flow | -23.14M - | -38.95M 68.28% | -62.47M 60.40% | -107.83M 72.61% | -160.42M 48.77% | -148.76M 7.27% | -70.56M 52.57% | |
capital expenditure | -802.48K - | -5.20M 547.66% | -8.44M 62.38% | -2.15M 74.57% | -852K 60.30% | -3.89M 357.04% | -10.07M 158.58% | |
free cash flow | -23.95M - | -44.15M 84.35% | -70.91M 60.63% | -109.98M 55.09% | -161.27M 46.64% | -152.65M 5.34% | -80.63M 47.18% |
All numbers in USD (except ratios and percentages)